Merck & Co., Inc. (MRK)
150.72
-1.83
(-1.20%)
USD |
NYSE |
Aug 24, 16:00
151.39
+0.67
(+0.44%)
After-Hours: 19:20
Merck Price to Book Value : 8.873 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 8.981 |
| August 20, 2026 | 8.771 |
| August 19, 2026 | 8.960 |
| August 18, 2026 | 7.958 |
| August 17, 2026 | 8.005 |
| August 14, 2026 | 7.997 |
| August 13, 2026 | 7.98 |
| August 12, 2026 | 7.825 |
| August 11, 2026 | 7.678 |
| August 10, 2026 | 7.707 |
| August 07, 2026 | 7.570 |
| August 06, 2026 | 7.557 |
| August 05, 2026 | 7.555 |
| August 04, 2026 | 7.536 |
| August 03, 2026 | 7.522 |
| July 31, 2026 | 7.665 |
| July 30, 2026 | 7.641 |
| July 29, 2026 | 7.674 |
| July 28, 2026 | 7.760 |
| July 27, 2026 | 7.698 |
| July 24, 2026 | 7.716 |
| July 23, 2026 | 7.682 |
| July 22, 2026 | 7.504 |
| July 21, 2026 | 7.433 |
| July 20, 2026 | 7.324 |
| Date | Value |
|---|---|
| July 17, 2026 | 7.506 |
| July 16, 2026 | 7.514 |
| July 15, 2026 | 7.277 |
| July 14, 2026 | 7.110 |
| July 13, 2026 | 7.302 |
| July 10, 2026 | 7.273 |
| July 09, 2026 | 7.363 |
| July 08, 2026 | 7.417 |
| July 07, 2026 | 7.586 |
| July 06, 2026 | 7.464 |
| July 02, 2026 | 7.627 |
| July 01, 2026 | 7.381 |
| June 30, 2026 | 7.565 |
| June 29, 2026 | 6.965 |
| June 26, 2026 | 6.926 |
| June 25, 2026 | 6.753 |
| June 24, 2026 | 6.492 |
| June 23, 2026 | 6.438 |
| June 22, 2026 | 6.216 |
| June 18, 2026 | 6.130 |
| June 17, 2026 | 6.214 |
| June 16, 2026 | 6.200 |
| June 15, 2026 | 6.185 |
| June 12, 2026 | 6.409 |
| June 11, 2026 | 6.501 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 7.739 |
| Eli Lilly & Co. | 34.67 |
| Pfizer Inc. | 1.872 |
| Bristol Myers Squibb Co. | 6.161 |
| Abbott Laboratories | 3.950 |
Price to Book Value Related Metrics
| PE Ratio | 120.47 |
| PS Ratio | 5.643 |
| Price to Free Cash Flow | 23.29 |
| Price | 150.72 |
| Earnings Yield | 0.83% |
| Market Cap | 372.07B |
| Operating PE Ratio | 30.01 |
| Normalized PE Ratio | 49.83 |